Dimensional Fund Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

Dimensional Fund Advisors’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-531,873	Closed	-$10M	–	3452
2019 Q3	$10M	Buy	531,873 +13,196	+3%	+$151K	﹤0.01%	2337
2019 Q2	$6.1M	Sell	518,677 -644,049	-55%	-$7.8M	﹤0.01%	2581
2019 Q1	$15.9M	Buy	1,162,726 +721	+0.1%	+$9.34K	0.01%	2181
2018 Q4	$11.9M	Buy	1,162,005 +215,098	+23%	+$2.75M	0.01%	2250
2018 Q3	$15.8M	Buy	946,907 +104,489	+12%	+$1.89M	0.01%	2243
2018 Q2	$13.3M	Buy	842,418 +19,634	+2%	+$298K	0.01%	2294
2018 Q1	$10.4M	Buy	822,784 +231,859	+39%	+$3.35M	﹤0.01%	2359
2017 Q4	$6.77M	Buy	590,925 +52,296	+10%	+$584K	﹤0.01%	2514
2017 Q3	$6.6M	Buy	538,629 +393,872	+272%	+$4.11M	﹤0.01%	2514
2017 Q2	$1.66M	Buy	144,757 +117,660	+434%	+$2.18M	﹤0.01%	2889
2017 Q1	$564K	Buy	+27,097	New	+$600K	﹤0.01%	3077

Dimensional Fund Advisors's ALDR Position: Q4 2019 in Review

Dimensional Fund Advisors sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 531,873 shares — an estimated $10M sold.

Dimensional Fund Advisors first reported a position in ALDR in Q1 2017 and held it in 11 quarters. The position peaked at $15.9M in Q1 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Dimensional Fund Advisors reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Dimensional Fund Advisors sold 531,873 Alder Biopharmaceuticals shares in Q4 2019, an estimated $10M.
Dimensional Fund Advisors first reported a position in Alder Biopharmaceuticals in Q1 2017 and held it in 11 quarters.
Dimensional Fund Advisors's Alder Biopharmaceuticals position peaked at $15.9M in Q1 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Dimensional Fund Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.